Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on UDCA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115806578A details a novel Nor-UDCA synthesis from Phocacholic Acid using CO2-assisted oxidation, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel plant-derived synthesis route for Ursodeoxycholic Acid ensures high purity and supply continuity. Ideal for pharmaceutical intermediates manufacturing.
Novel stigmasterol based UDCA preparation method ensures high purity and supply chain stability for pharmaceutical intermediates manufacturing processes.
Patent CN105368828A enables high-yield UDCA synthesis via recombinant E. coli ensuring supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Patent CN110669091A reveals a novel DIPEA salt crystallization method for high-purity ursodeoxycholic acid, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced purification process for ursodeoxycholic acid ensures 99.8% purity. Optimized solvent usage reduces energy consumption for reliable pharmaceutical intermediate supply chains.
Advanced P450 enzyme mutant technology enables efficient ursodeoxycholic acid production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN114539342B reveals an industrial method for TUDCA using alcohol solvents to reduce impurities, offering cost-effective pharma intermediate manufacturing.
Patent CN112588319A reveals a novel silane-catalyzed route for TUDCA synthesis, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN118745205A details a plant-derived ursodeoxycholic acid synthesis avoiding animal risks. Offers high purity and scalable supply chain solutions.
Patent CN118638174A reveals a plant-based UDCA synthesis route. Achieve 99.91% purity with reduced viral risk and scalable enzymatic steps for reliable supply.
Patent CN119119158A reveals a novel plant-derived route for ursodeoxycholic acid. Achieve high purity and cost reduction in API manufacturing with scalable bio-hybrid synthesis.
Patent CN105330715B enables high-purity TUDCA synthesis with improved supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN107099516A details high-efficiency enzymatic UDCA production. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN115181150A details a green synthesis of UDCA from phytosterol derivatives, offering high yield and reduced chromium pollution for reliable API intermediate supply.
Patent CN109402212B reveals a novel fusion enzyme method for TUDCA production, offering significant cost reduction in bile acid manufacturing and reliable supply chain scalability.
Patent CN119119158B reveals a novel plant-derived synthesis route for ursodeoxycholic acid offering significant supply chain stability and cost reduction advantages.
Patent CN102718829B reveals high-yield TUDCA synthesis avoiding ion-exchange columns ensuring cost reduction and supply reliability for global pharmaceutical intermediates
Patent CN114592027A reveals a novel two-step method for Tauroursodeoxycholic Acid production, offering significant cost reduction in API manufacturing and high-purity outcomes.
Patent CN114958699A reveals a novel dual-enzyme co-expression strategy for ursodeoxycholic acid, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing.